ABSTRACT:
Pregnancy involves significant physiological changes, and the emergence or exacerbation of medical conditions during this period poses substantial risks to both maternal and fetal health. Among the most critical conditions encountered are Human Immunodeficiency Virus (HIV), Gestational Hypertension (GHT), Gestational Diabetes Mellitus (GDM), and Gestational Thyroidism (thyroid dysfunction). These disorders require diligent screening, monitoring, and management as they are associated with a range of adverse outcomes, including preeclampsia, preterm birth, fetal growth restriction, congenital anomalies, neonatal complications (e.g., hypoglycemia, respiratory distress), and an increased long-term risk of chronic diseases for the mother. HIV in pregnancy, while a serious concern, has seen improved outcomes with the advent of Highly Active Antiretroviral Therapy (HAART), which significantly lowers the risk of maternal-to-child transmission. However, HAART use has been linked to an increased risk of GDM and GHT, highlighting the need for integrated care and close monitoring. GDM, characterized by glucose intolerance during gestation, affects a significant percentage of pregnancies and requires lifestyle interventions and potentially medication to prevent complications like macrosomia and preeclampsia. GHT, new-onset hypertension after 20 weeks of gestation, can progress to preeclampsia, a severe condition necessitating careful management to prevent eclampsia and other complications. Gestational thyroid dysfunction, particularly hypothyroidism, is frequently undiagnosed due to nonspecific symptoms but is crucial for fetal neurodevelopment, making universal or targeted screening protocols essential. The management of these coexisting conditions requires a multidisciplinary and coordinated approach involving obstetricians, endocrinologists, infectious disease specialists, and other healthcare professionals. Early diagnosis through universal screening, comprehensive patient education, and integrated antenatal care models are vital to optimize outcomes for both mother and child. Further research is needed to better understand the complex interplay of these conditions and develop more targeted interventions and long-term follow-up strategies.